Workflow
祥生医疗跌2.00%,成交额2621.48万元,主力资金净流入109.62万元

Core Viewpoint - Xiangsheng Medical's stock has shown volatility with a year-to-date increase of 29.71%, but a recent decline of 12.45% over the past 20 days indicates potential concerns in market performance [1][2]. Financial Performance - For the first half of 2025, Xiangsheng Medical reported revenue of 236 million yuan, a year-on-year decrease of 4.61%, and a net profit attributable to shareholders of 69.7 million yuan, down 14.32% compared to the previous year [2]. - Cumulative cash dividends since the company's A-share listing amount to 464 million yuan, with 280 million yuan distributed over the last three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders increased by 1.87% to 6,631, while the average number of circulating shares per person decreased by 1.84% to 16,909 shares [2]. - Among the top ten circulating shareholders, notable changes include a stable holding of 603,300 shares by Changcheng Consumption Value Mixed A, while Huazhong Hongli Mixed A reduced its holdings by 567,400 shares [3]. Market Activity - On September 9, 2023, Xiangsheng Medical's stock price was 30.38 yuan per share, with a trading volume of 26.21 million yuan and a turnover rate of 0.76% [1]. - The stock has appeared on the "Dragon and Tiger List" twice this year, with the most recent occurrence on February 17 [1].